美的集團(000333.SZ):共893.1萬份股票期權將開始行權
格隆匯6月22日丨美的集團(000333.SZ)公佈,公司於2021年6月5日公吿公司第五期股權激勵計劃首次授予第二個行權期行權條件已經成就,經深圳證券交易所及中國證券登記結算有限責任公司深圳分公司審核,公司第五期股權激勵計劃確定並通過考核的1015名激勵對象可以在第二個行權期內行使其獲得行權資格的共893.10萬份股票期權。
第五期股權激勵計劃首次授予第二個行權期正式開始行權時間為2021年6月23日。此次自主行權股票期權的期權代碼:037062;期權簡稱:美的JLC5。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.